alterations in gastrointestinal function dr. gerrard uy
TRANSCRIPT
Dysphagia
• a sensation of "sticking" or obstruction of the passage of food through the mouth, pharynx, or esophagus
• often used as an umbrella term to include other symptoms related to swallowing difficulty
Definition of terms
• Aphagia – signifies complete esophageal obstruction
• Odynophagia– painful swallowing
• Globus pharyngeus – is the sensation of a lump lodged in the throat
• Phagophobia– meaning fear of swallowing
Pathophysiology of Dysphagia
• oral, pharyngeal, and esophageal • mechanical dysphagia - caused by a large
bolus or a narrow lumen• motor dysphagia - due to weakness of
peristaltic contractions or to impaired deglutitive inhibition causing nonperistaltic contractions and impaired sphincter relaxation
Oral phase dysphagia
• associated with poor bolus formation and control
• food may either drool out of the mouth or overstay in the mouth
• patient may experience difficulty in initiating the swallowing reflex
• premature spillage of food into the pharynx and aspiration into the unguarded larynx and/or nasal cavity
Pharyngeal phase Dysphagia
• associated with stasis of food in the pharynx due to poor pharyngeal propulsion and obstruction at the UES
• leads to nasal regurgitation and laryngeal aspiration during or after a swallow
• Nasal regurgitation and laryngeal aspiration during the process of swallowing are hallmarks
Esophageal Dysphagia
• the esophageal lumen can distend up to 4 cm – When the esophagus cannot dilate beyond 2.5 cm
in diameter, dysphagia to normal solid food can occur
– when the esophagus can’t distend beyond 1.3 cm, dysphagia ALWAYS occurs
History
• can provide a presumptive diagnosis in >80% of patients
• Nasal regurgitation and tracheobronchial aspiration with swallowing are hallmarks of pharyngeal paralysis or a tracheoesophageal fistula
• Hoarseness– precedes dysphagia, the primary lesion is usually in
the larynx– following dysphagia may suggest involvement of the
recurrent laryngeal nerve
History
• Type of food– Difficulty only with solids implies mechanical
dysphagia with a lumen that is not severely narrowed
– dysphagia occurs with liquids as well as solids in advanced obstruction
• Duration– Transient dysphagia may be due to an
inflammatory process– Progressive, lasting days to weeks - carcinoma
Physical Examination
• Careful inspection of the mouth and pharynx• Neck should be examined for thyromegaly or
spinal abnormality• Physical examination is often unrevealing in
esophageal dysphagia
Heartburn
• Pyrosis• Characterized by burning retrosternal discomfort
that may move up and down the chest• Characteristic symptom of reflux esophagitis• Aggravated by bending forward, straining, or
lying recumbent• Worse after meals• Relieved by upright posture, swallowing saliva or
water, and antacids
Odynophagia
• Painful swallowing• characteristic of non reflux esophagitis,
herpes, and pill induced esophagitis• May occur with peptic ulcer of the esophagus,
carcinoma, and caustic damage
Regurgitation
• Effortless appearance of gastric or esophageal contents in the mouth
• Associated with incompetence of both UES and LES
• May result in chronic coughm, laryngitis, and laryngeal aspiration
• Water Brash – reflex salivary hypersecretion that occurs in response to peptic esophagitis
Peptic Ulcer Disease
• Characterized by burning epigastric pain exacerbated by fasting and improved with meals
• Ulcer – disruption of the mucosal integrity of the stomach and/or duodenum leading to a local defect or excavation due to active inflammation
Gastroduodenal Mucosal Defense
• Preepithelial– Mucus– Bicarbonate– Surface actvie phospholipids
• Epithelial– Cellular resistance– Restitution– Growth factors– Cell proliferation
Mucus Bicarbonate Layer
• First line of defense• Serves as a physicochemical barrier to
multiple molecules• Mucous gel functions as a nonstirred water
layer impeding diffusion of ions and molecules such as pepsin
• Bicarbonate forms a ph gradient from 1 to 2 at the gastric luminal surface
Cellular Resistance
• Next line of defense• Consist of ionic transporters maintaining
intracellular ph• Intracellular tight junctions
Restitution
• If the preepithelial barrier were breached, gastric epithelial cells bordering the site of injury can migrate to restore a damaged region
• Occurs independent of cell division
Cellular Proliferation
• When larger defects are present that are not effectively repaired by restitution
• Regulated by prostaglandins and growth factors
Prostaglandins
• Play a central role in gastric epithelial defense• Functions:– Regulate the release of mucosal bicarbonate and
mucus– Inhibit parietal cell secretion– Maintains mucosal blood flow and epithelial
restitution
Prostaglandins
• Derived from arachidonic acid, which is formed from phospholipids
• rate limiting enzyme is cyclooxygenase (COX)• 2 isoforms – cox1 and cox2• COX1 – constitutively expressed– Stomach– Platelets– Kidneys– Endothelial cells
Prostaglandins
• COX2 – inducible by inflammatory stimuli– Macrophages– Leukocytes– Fibroblasts– Synovial cells
Subepithelial Defense
• Key component is the elaborate microvascular system providing HCO3
• Neutralizes acid generated by the parietal cells
• Provides adequate supply of micronutrients and oxygen while removing toxic metabolites
Physiology of Gastric Secretion
• Hydrochloric acid and pepsinogen – principal gastric secretory products capable of
inducing mucosal injury
• Acid secretion occurs under basal and stimulated conditions
• Basal secretion is controlled by cholinergic input via vagus nerve and histaminergic input from local gastric sources
Physiology of Gastric Secretion
• 3 phases of stimulated gastric acid secretion– Cephalic– Gastric– intestinal
Physiology of Gastric Secretion
• Cephalic– Sight, smell, and taste of food– Stimulates gastric secretion via vagus nerve
• Gastric– Activated once food enters the stomach– Driven by amino acids and amines that directly
stimulate the G cells to release gastrin
Physiology of Gastric Secretion
• Intestinal– Mediated by luminal distention and nutrient
assimilation
Pathophysiologic Basis of Peptic Ulcer Disease
• Encompasses both gastric and duodenal ulcers• Ulcers are defined as breaks in the mucosal
surface > 5mm in size with depth to the submucosa
Peptic Ulcer Disease
Gastric Ulcers• occur later in life• More common in males• Can represent a malignancy• Benign GUs most often
found distal to the junction of the antrum and mucosa
• H. pylori and NSAID induced injury
Duodenal Ulcers• Occur most often in the first
portion of the duodenum (90% - within 3cm of the pylorus)
• Usually < 1cm in diameter• Malignany is rare• H. pylori and NSAID induced
injury
H. Pylori and Acid Peptic Disease
• Initially named Campylobacter pyloridis• Gram negative microaerophilic rod• Most commonly found in the deeper portions
of the mucous gel coating the gastric mucosa• Under normal conditions, does not invade
cells• S – shaped and contains multiple sheathed
flagella
H. Pylori and Acid Peptic Disease
• First step in infection is dependent on the bacteria’s motility and its ability to produce urease
Epidemiology
• In developing countries, 80% maybe infected by the age of 20
• 20 – 50% in industrialized countries
Epidemiology
• Factors that favor colonization rate– Poor socioeconomic status– Less education– Birth or residence in a developing country– Domestic crowding– Unsanitary living conditions– Unclean food and water– Exposure to gastric contents of infected
individuals
Pathophysiology
• Virtually always associated with chronic active gastritis
• Only 10-15% develop frank peptic ulceration• Bacterial factors:– Urease– Chemotactic surface factors– protease
• Host factors:– Inflammatory response
Pathogenetic Factors in Acid Peptic Disease
• Cigarette smoking– Decrease healing rates– Impair response to therapy– Increases ulcer related complications
• Genetic predisposition– Blood group O
• Psychological stress
Pathogenetic Factors in Acid Peptic Disease
• Diet– Highly acidic diet– Beverages containing alcohol and caffeine
• Chronic Disorders– Systemic mastocytosis– Chronic pulmonary disease– Chronic renal failure– Cirrhosis
Pathogenetic Factors in Acid Peptic Disease
• Chronic Disorders– Nephrolithiasis– Polycythemia vera– Coronary artery disease– Chronic pancreatitis
Clinical Features
• Epigastric pain – burning/gnawing discomfort• Usually ill defined, aching sensation or as
hunger pain• DU– Pain occurs 90 mins to 3 hrs after a meal– Frequently relieved by antacids or food– Awakens the patient from sleep (between
midnight and 3am)
Clinical Features
• GU– Discomfort is usually precipitated by food– Nausea and weight loss is more common
Modified Johnsons Classification
• Type I: Ulcer along the body of the stomach, most often along the lesser curve at incisura angularis along the locus minoris resistantiae
• Type II: Ulcer in the body in combination with duodenal ulcers. Associated with acid oversecretion.
• Type III: In the pyloric channel within 3 cm of pylorus. Associated with acid oversecretion.
Modified Johnsons Classification
• Type IV: Proximal gastroesophageal ulcer• Type V: Can occur throughout the stomach.
Associated with chronic NSAID use (such as aspirin)
Physical Examination
• Epigastric tenderness – most frequent finding• Tachycardia suggests dehydration• Severe boardlike abdomen suggests
perforation• Succussion splash indicates retained fluid in
the stomach suggesting gastric outlet obstruction
PUD related Complications
• Gastrointestinal bleeding– Most common complication
• Perforation– 2nd most common– DUs tend to penetrate posteriorly into the panceas– Gus tend to penetrate into the left hepatic lobe
• Gastric Outlet Obstruction– Least common occurring in 1 – 2% of patients
Differential Diagnosis
• Nonulcer dyspepsia (NUD)– Functional dyspepsia or essential dyspepsia– Heterogeneous disorders typified by upper
abdominal pain without ulceration
• Proximal gastrointestinal tumors• GERD• Pancretobiliary disease• Gastroduodenal crohn’s disease
Diagnostic Evaluation
• Endoscopy– most sensitive and specific approach– Permits direct visualization of the mucosa– Tissue biopsy can be done to rule out malignancy
• Serology• Urea breath test• Stool antigen
Treatment
• Acid neutralizing/Inhibitory drugs– Antacids• Aluminum hydroxide• Magnesium hydroxide• Ca carbonate• Na bicarbonate
– H2 receptor antagonist• Famotidine• Cimetidine• ranitidine
Treatment
• Acid neutralizing/Inhibitory drugs– Proton pump inhibitors• Omeprazole• Esomeprazole• Lansoprazole• pantoprazole